AILERON

Aileron Therapeutics, Inc.

Application Filed: 2007-02-15
Trademark Application Details
Trademark Logo AILERON

Mark For: AILERON™ trademark registration is intended to cover the categories of pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes.

Status

2021-07-25 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number77108337
Mark Literal ElementsAILERON
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationINTENT TO USE SECTION 2010-04-05
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAaron Hendelman
Attorney Docket Number35224-900
Law Office AssignedM40
Employee NameREGAN, JOHN B

Timeline

2007-02-15Application Filed
2008-12-16Published
2008-12-16Published for Opposition
2010-04-05Location: INTENT TO USE SECTION
2012-04-09Abandon
2012-04-09Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2012-04-09Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Aileron Therapeutics, Inc.
Address281 Albany Street Cambridge, MASSACHUSETTS UNITED STATES 02139
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

Aaron Hendelman
650 Page Mill Road
Palo Alto CA 94304


Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2012-04-09
ABANDONMENT - NO USE STATEMENT FILED2012-04-0999999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2011-09-06
EXTENSION 5 GRANTED2011-09-0366154
TEAS EXTENSION RECEIVED2011-09-02
EXTENSION 5 FILED2011-09-0266154
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2011-03-11
EXTENSION 4 GRANTED2011-03-1066154
TEAS EXTENSION RECEIVED2011-03-04
EXTENSION 4 FILED2011-03-0466154
TEAS CHANGE OF OWNER ADDRESS RECEIVED2011-01-12
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2011-01-1288888
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2010-09-14
EXTENSION 3 GRANTED2010-09-1366154
TEAS EXTENSION RECEIVED2010-09-10
EXTENSION 3 FILED2010-09-1066154
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2010-04-06
EXTENSION 2 GRANTED2010-04-0566154
CASE ASSIGNED TO INTENT TO USE PARALEGAL2010-04-0566154
TEAS EXTENSION RECEIVED2010-03-10
EXTENSION 2 FILED2010-03-1066154
TEAS EXTENSION RECEIVED2009-09-10
EXTENSION 1 GRANTED2009-09-1098765
EXTENSION 1 FILED2009-09-1098765
NOA MAILED - SOU REQUIRED FROM APPLICANT2009-03-10
PUBLISHED FOR OPPOSITION2008-12-16
NOTICE OF PUBLICATION2008-11-26
LAW OFFICE PUBLICATION REVIEW COMPLETED2008-11-1078145
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2008-11-076328
EXAMINERS AMENDMENT E-MAILED2008-11-076328
EXAMINERS AMENDMENT -WRITTEN2008-11-0777658
EXAMINER'S AMENDMENT ENTERED2008-11-0788888
APPROVED FOR PUB - PRINCIPAL REGISTER2008-11-07
NOTIFICATION OF FINAL REFUSAL EMAILED2008-07-10
FINAL REFUSAL WRITTEN2008-07-1077658
FINAL REFUSAL E-MAILED2008-07-10
TEAS/EMAIL CORRESPONDENCE ENTERED2008-06-2488889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2008-06-24
CORRESPONDENCE RECEIVED IN LAW OFFICE2008-06-2488889
ASSIGNED TO LIE2008-06-2478145
TEAS CHANGE OF OWNER ADDRESS RECEIVED2008-02-20
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2008-02-2088888
PRIORITY ACTION WRITTEN2007-12-2677658
PRIORITY ACTION E-MAILED2007-12-266326
NOTIFICATION OF PRIORITY ACTION E-MAILED2007-12-266326
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2007-12-14
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2007-12-14
TEAS/EMAIL CORRESPONDENCE ENTERED2007-12-0688889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2007-12-04
CORRESPONDENCE RECEIVED IN LAW OFFICE2007-12-0488889
NON-FINAL ACTION WRITTEN2007-06-0677658
NON-FINAL ACTION MAILED2007-06-06
ASSIGNED TO EXAMINER2007-06-0577658
NEW APPLICATION ENTERED IN TRAM2007-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed